↩ Go Back
Need help?

Generic Pharmaceuticals Company Investment Opportunity in New York, United States

Generic complex injectable pharmaceutical manufacturer with 5 drugs pending approval and proven track record.
This Business is on a Premium Plan
Established 5-10 year(s)
Employees 10 - 50
Legal Entity Limited Liability Company (LLC)
Reported Sales Nil
Run Rate Sales Nil
EBITDA Margin Nil
Industries Generic Pharmaceuticals
Locations  New York
Local Time 6:11 AM US / Eastern
Listed By Management Member
Status Active
Overall Rating
Partial Stake Sale
USD 20 million for 5.0% stake (Native Currency: USD 20,000,000)
Reason: Expansion of existing facility to manufacture additional drugs.
Includes physical assets worth USD 18 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Pharma Setup
Business Overview

- The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company.

- They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months.

- The facility was inspected very recently by the FDA and passed.

- We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors.

- The company should be worth USD 2B in another 3 years.

- The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.

Products & Services Overview

We have 5 drugs in the pipeline. Information is attached. The drugs are all generic and we are only 1 of 2/3 facilities in the United States that are able to manufacture complex injectables.

Assets Overview

Specialized equipment for the manufacturing of complex injectables. The business also owns land of 27 acres.

Facilities Overview

27 acres of own land, 50,000 sqft of building space in East Windsor.

Capitalization Overview

Friends, family, and distribution contracts.

USD 4.2M - outstanding loan on the existing building.

USD 3M - 2nd deposit on specialized equipment that is being manufactured in Europe.

There are 7 shareholders in the business.

Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business

14 Investors viewed this Business this month.
Register below to connect now!

Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

    Frequently
    Asked
    Questions

    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more